Compare ASPI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASPI | CTKB |
|---|---|---|
| Founded | 2021 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.3M | 541.1M |
| IPO Year | 2022 | 2021 |
| Metric | ASPI | CTKB |
|---|---|---|
| Price | $4.04 | $4.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $12.00 | $5.63 |
| AVG Volume (30 Days) | ★ 4.0M | 745.6K |
| Earning Date | 04-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $23,849,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $68.41 | $5.42 |
| Revenue Next Year | $126.69 | $7.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 475.48 | 17.67 |
| 52 Week Low | $3.51 | $3.28 |
| 52 Week High | $14.49 | $6.18 |
| Indicator | ASPI | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 38.29 | 38.41 |
| Support Level | $3.86 | $4.13 |
| Resistance Level | $5.88 | $4.49 |
| Average True Range (ATR) | 0.32 | 0.17 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 30.40 | 7.58 |
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.